12-111214215-G-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_015267.4(CUX2):c.79G>T(p.Val27Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000508 in 1,496,796 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V27I) has been classified as Uncertain significance.
Frequency
Consequence
NM_015267.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CUX2 | NM_015267.4 | c.79G>T | p.Val27Phe | missense_variant | 2/22 | ENST00000261726.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CUX2 | ENST00000261726.11 | c.79G>T | p.Val27Phe | missense_variant | 2/22 | 1 | NM_015267.4 | P1 | |
CUX2 | ENST00000397643.3 | c.259G>T | p.Val87Phe | missense_variant | 3/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000470 AC: 64AN: 136190Hom.: 1 Cov.: 30
GnomAD3 exomes AF: 0.000312 AC: 63AN: 202220Hom.: 0 AF XY: 0.000333 AC XY: 37AN XY: 111174
GnomAD4 exome AF: 0.000512 AC: 697AN: 1360546Hom.: 0 Cov.: 28 AF XY: 0.000479 AC XY: 323AN XY: 674562
GnomAD4 genome AF: 0.000470 AC: 64AN: 136250Hom.: 1 Cov.: 30 AF XY: 0.000431 AC XY: 28AN XY: 65004
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | CUX2: BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Developmental and epileptic encephalopathy, 67 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 18, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at